Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline in Newly Diagnosed Ocular Adnexal Marginal Zone Lymphoma
NCT01820910Phase 2Completed
- Sponsor
- International Extranodal Lymphoma Study Group
- Start
- Mar 2013
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of doxycycline in Ocular adnexal marginal zone lymphoma (OAL), sponsored by International Extranodal Lymphoma Study Group. Started Mar 2013; status: completed.
02
Drugs
doxycycline
03
Conditions
Ocular adnexal marginal zone lymphoma (OAL)
Beyond the preview
Go deeper on NCT01820910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01820910.